ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 126 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,545 | -72.9% | 261,712 | +4.8% | 0.00% | – |
| Q2 2023 | $127,390 | -19.4% | 249,784 | -0.4% | 0.00% | – |
| Q1 2023 | $157,971 | -10.6% | 250,748 | -7.8% | 0.00% | – |
| Q4 2022 | $176,689 | -64.4% | 271,829 | -5.8% | 0.00% | – |
| Q3 2022 | $496,000 | +48.9% | 288,597 | +7.6% | 0.00% | – |
| Q2 2022 | $333,000 | +52.8% | 268,175 | -19.9% | 0.00% | – |
| Q1 2022 | $218,000 | -80.3% | 334,744 | -67.0% | 0.00% | – |
| Q4 2021 | $1,106,000 | -17.0% | 1,014,456 | +38.5% | 0.00% | – |
| Q3 2021 | $1,333,000 | +42.1% | 732,435 | +106.3% | 0.00% | – |
| Q2 2021 | $938,000 | -63.6% | 355,102 | -50.5% | 0.00% | -100.0% |
| Q1 2021 | $2,580,000 | +152.4% | 716,745 | +76.7% | 0.00% | – |
| Q4 2020 | $1,022,000 | -9.0% | 405,601 | -9.0% | 0.00% | – |
| Q3 2020 | $1,123,000 | -38.2% | 445,631 | -19.6% | 0.00% | -100.0% |
| Q2 2020 | $1,817,000 | +14.6% | 554,064 | -14.3% | 0.00% | 0.0% |
| Q1 2020 | $1,585,000 | -51.3% | 646,873 | -6.2% | 0.00% | 0.0% |
| Q4 2019 | $3,257,000 | -19.5% | 689,977 | -27.0% | 0.00% | -50.0% |
| Q3 2019 | $4,047,000 | +25.4% | 945,537 | +70.9% | 0.00% | +100.0% |
| Q2 2019 | $3,226,000 | +81.2% | 553,384 | +19.6% | 0.00% | 0.0% |
| Q1 2019 | $1,780,000 | +25.5% | 462,522 | -39.0% | 0.00% | 0.0% |
| Q4 2018 | $1,418,000 | -13.0% | 758,282 | +49.0% | 0.00% | 0.0% |
| Q3 2018 | $1,629,000 | -0.1% | 508,875 | -5.8% | 0.00% | 0.0% |
| Q2 2018 | $1,631,000 | -52.3% | 540,151 | -38.1% | 0.00% | 0.0% |
| Q1 2018 | $3,420,000 | +28.2% | 872,376 | +35.3% | 0.00% | 0.0% |
| Q4 2017 | $2,668,000 | -36.6% | 644,564 | -6.0% | 0.00% | -50.0% |
| Q3 2017 | $4,210,000 | +2.5% | 685,580 | +3.8% | 0.00% | 0.0% |
| Q2 2017 | $4,107,000 | -11.3% | 660,391 | -9.6% | 0.00% | 0.0% |
| Q1 2017 | $4,630,000 | +6.2% | 730,291 | -10.4% | 0.00% | 0.0% |
| Q4 2016 | $4,359,000 | +26.1% | 814,844 | +32.7% | 0.00% | 0.0% |
| Q3 2016 | $3,456,000 | -10.4% | 613,853 | -12.6% | 0.00% | 0.0% |
| Q2 2016 | $3,857,000 | -10.3% | 702,598 | +21.2% | 0.00% | -33.3% |
| Q1 2016 | $4,301,000 | -42.9% | 579,663 | -36.1% | 0.00% | -40.0% |
| Q4 2015 | $7,538,000 | +54.9% | 907,117 | +67.9% | 0.01% | +66.7% |
| Q3 2015 | $4,867,000 | +2.9% | 540,177 | +37.0% | 0.00% | 0.0% |
| Q2 2015 | $4,731,000 | +16.0% | 394,232 | +4.1% | 0.00% | 0.0% |
| Q1 2015 | $4,080,000 | +149.5% | 378,859 | +17.4% | 0.00% | +200.0% |
| Q4 2014 | $1,635,000 | – | 322,584 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |